Select Equity Group, L.P. Repligen Corp Transaction History

Select Equity Group, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $132 Million - $176 Million	-936,086 Reduced 99.53%	4,418 $717,000
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $3.09 Million - $4.94 Million	-19,166 Reduced 2.0%	940,504 $177 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $80.7 Million - $99.3 Million	-326,126 Reduced 25.36%	959,670 $254 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $1.8 Million - $2.99 Million	-9,217 Reduced 0.71%	1,285,796 $372 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $7.2 Million - $9.59 Million	43,409 Added 3.47%	1,295,013 $259 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $2.37 Million - $2.97 Million	13,120 Added 1.06%	1,251,604 $243 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $1.11 Million - $1.54 Million	-7,470 Reduced 0.6%	1,238,484 $237 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $25.4 Million - $32.9 Million	207,717 Added 20.01%	1,245,954 $184 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $52 Million - $77.4 Million	551,220 Added 113.18%	1,038,237 $128 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $41.4 Million - $53.2 Million	487,017 New	487,017 $47 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Select Equity Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Select Equity Group, L.P. with notifications on news.